Financial Summary (All financials)
In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 |
Revenues | 164.5 | 141.3 | 111.6 | 90.9 | 78.0 | 58.9 |
Revenue growth | 16.4% | 26.6% | 22.7% | 16.6% | 32.4% | |
Cost of goods sold | 27.3 | 24.4 | 17.9 | 14.8 | 12.6 | 9.5 |
Gross profit | 137.2 | 116.8 | 93.6 | 76.1 | 65.4 | 49.4 |
Gross margin | 83.4% | 82.7% | 83.9% | 83.8% | 83.9% | 83.9% |
Sales and marketing | 109.1 | 87.5 | 67.7 | 51.8 | 42.3 | 29.1 |
Research and development | 11.8 | 12.3 | 9.4 | 10.8 | 9.0 | 8.2 |
General and administrative | 38.8 | 27.7 | 18.9 | 14.8 | 11.1 | 8.5 |
EBITA | -21.6 | -10.1 | -1.8 | -0.8 | 3.4 | 3.6 |
EBITA margin | -13.1% | -7.2% | -1.6% | -0.9% | 4.3% | 6.1% |
Amortization of intangibles | 0.9 | 0.6 | 0.5 | 0.4 | 0.4 | |
EBIT | -22.5 | -10.7 | -2.3 | -1.3 | 3.0 | 3.6 |
EBIT margin | -13.7% | -7.6% | -2.1% | -1.4% | 3.8% | 6.1% |
Pre-tax income | -21.9 | -9.5 | -26.3 | -8.5 | -0.5 | 2.6 |
Income taxes | -6.1 | 1.4 | 1.7 | 1.2 | 1.3 | 0.7 |
Tax rate | 27.7% | | | | | 25.8% |
Net income | -15.9 | -11.0 | -27.9 | -9.7 | -1.8 | 1.9 |
Net margin | -9.6% | -7.8% | -25.0% | -10.7% | -2.3% | 3.3% |
|
Diluted EPS | ($0.57) | ($0.43) | ($3.09) | ($2.10) | ($0.41) | $0.38 |
Shares outstanding (diluted) | 27.8 | 25.3 | 9.0 | 4.6 | 4.5 | 5.0 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|